Toggle navigation

SPINRAZA is given through a procedure called intrathecal injection, and can only be done at designated treatment centers by, or under the direction of, a qualified healthcare provider (HCP).

Type in your ZIP code below and click “Find Location” to see a list of treatment centers in your area. You can sort the results by centers that treat children or adults with spinal muscular atrophy (SMA). You will also find a list of questions below the search results to help you determine which treatment center may best suit your needs.

The locator tool is continually updated with new locations that are administering SPINRAZA, so be sure to check back and see if there are any new treatment centers in your area.

Treatment Center Locations

Biogen does not receive payment for this service and we do not endorse or recommend any treatment center. Further, we do not have oversight of and are not responsible for the actions of any treatment center.

Biogen does not guarantee immediate availability at any particular treatment center. Every individual is unique, and only after careful medical evaluation can a course of treatment be determined. 

You are ultimately responsible for the selection of a treatment center and it is an important decision that you should consider carefully. Your HCP is your primary resource and should be consulted as you use this locator tool. 

Here are some questions to help you determine which treatment center best suits your needs:

Are you currently accepting new patients?

Do you treat individuals with SMA across all ages and SMA types?

Does my health insurance cover the costs for the SPINRAZA treatment procedure at your center?

Do you have experience treating SMA patients with medical complexities/complications, such as growing rods, spinal fusion, etc?

How long does it take to get an initial appointment to discuss SPINRAZA treatment at your center?

Click here to download a discussion guide to refer to once you've found a treatment center.

IMPORTANT SAFETY INFORMATION

Increased risk of bleeding complications has been observed after administration of similar medicines. Your healthcare provider should perform blood tests before you start treatment with SPINRAZA and before each dose to monitor for signs of these risks. Seek medical attention if unexpected bleeding occurs.

Increased risk of kidney damage, including potentially fatal acute inflammation of the kidney, has been observed after administration of similar medicines. Your healthcare provider should perform urine testing before you start treatment with SPINRAZA and before each dose to monitor for signs of this risk.

The most common side effects of SPINRAZA include lower and upper respiratory infections, constipation, headache, back pain, and post-lumbar puncture syndrome.

These are not all of the possible side effects of SPINRAZA. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

This information is not intended to replace discussions with your healthcare provider.

Please see full Prescribing Information for additional Important Safety Information.

As a courtesy, our full Prescribing Information is also available en Español. For prescribing decisions, please refer to official approved labeling.


INDICATION

SPINRAZA is a prescription medicine used to treat spinal muscular atrophy (SMA) in pediatric and adult patients.